Thromboembolism Risk of JAK inhibitors with Concurrent Oral Contraceptive Use: A Global Multicenter Cohort Study

Authors

Jasmine Levine, Icahn School of Medicine at Mount Sinai, New York, NY
Rahib K. Islam, LSU Health Sciences Center - New OrleansFollow
Lillian Mo, Icahn School of Medicine at Mount Sinai, New York, NY
Nicholas Gulati, Icahn School of Medicine at Mount Sinai, New York, NY
Jonas Adalsteinsson, Icahn School of Medicine at Mount Sinai, New York, NY
Jordan Talia, Icahn School of Medicine at Mount Sinai, New York, NY
Shari R. Lipner, Weill Cornell Medicine, New York, NY
Benjamin Ungar, Icahn School of Medicine at Mount Sinai, New York, NY

Document Type

Article

Publication Date

4-23-2025

Publication Title

Clinical and Experimental Dermatology

PubMed ID

40265367

Recommended Citation

Levine, Jasmine; Islam, Rahib K.; Mo, Lillian; Gulati, Nicholas; Adalsteinsson, Jonas; Talia, Jordan; Lipner, Shari R.; and Ungar, Benjamin, "Thromboembolism Risk of JAK inhibitors with Concurrent Oral Contraceptive Use: A Global Multicenter Cohort Study" (2025). School of Medicine Faculty Publications. 3798.
https://digitalscholar.lsuhsc.edu/som_facpubs/3798
10.1093/ced/llaf178